Literature DB >> 15853684

Innate immunity and the heart.

Stefan Frantz1, Johann Bauersachs, Ralph A Kelly.   

Abstract

The immune system of higher vertebrates consists of two components: the innate and adaptive immunity. While the adaptive immune system relies on somatically generated and clonally selected antigen receptors, the innate immune system detects the presence of pathogens by their evolutionarily highly conserved, relatively invariant structural motifs. Interestingly, recent data suggest that activation of the innate immune system could play an important role in various diseases without the direct involvement of infectious pathogens. For example, a number of inflammatory cytokines, including TNF (tumor necrosis factor), IL (interleukin)-1beta, IL-6 and IL-8, as well as iNOS (inducible nitric oxide synthase), all components of innate immunity, are also implicated in ischemia/reperfusion injury, and in the abnormal myocardial remodeling characteristic of chronic heart failure. Understanding of the regulation and activation of the innate immune system in diseases not obviously related to an immune response to specific pathogen could provide new therapeutic targets for cardiovascular diseases. Thus, in this review, we provide a general overview of the components of innate immunity with a focus on humoral factors, their role in the response to foreign pathogens, and their potential role in the response to tissue injury (i.e., the "Expanded Self-Non-Self" and the "Danger" theories of immune activation).

Entities:  

Mesh:

Year:  2005        PMID: 15853684     DOI: 10.2174/1381612053507512

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

Review 1.  Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Authors:  Tuanzhu Ha; Li Liu; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

2.  Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.

Authors:  Stefan Frantz; Jochen Tillmanns; Peter J Kuhlencordt; Isabel Schmidt; Anna Adamek; Charlotte Dienesch; Thomas Thum; Steve Gerondakis; Georg Ertl; Johann Bauersachs
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

Review 3.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

4.  The Association between Cytokines and 365-Day Readmission or Mortality in Adult Cardiac Surgery.

Authors:  Allen D Everett; Shama S Alam; Sherry L Owens; Devin M Parker; Christine Goodrich; Donald S Likosky; Heather Thiessen-Philbrook; Moritz Wyler von Ballmoos; Kevin Lobdell; Todd A MacKenzie; Jeffrey Jacobs; Chirag R Parikh; Anthony W DiScipio; David J Malenka; Jeremiah R Brown
Journal:  J Extra Corpor Technol       Date:  2019-12

5.  Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.

Authors:  Dan Frenkel; Alok S Pachori; Lunan Zhang; Adi Dembinsky-Vaknin; Dorit Farfara; Sanja Petrovic-Stojkovic; Victor J Dzau; Howard L Weiner
Journal:  Int Immunol       Date:  2009-06-10       Impact factor: 4.823

6.  Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion.

Authors:  Ning Zou; Lihua Ao; Joseph C Cleveland; Xiaoping Yang; Xin Su; Guang-Yun Cai; Anirban Banerjee; David A Fullerton; Xianzhong Meng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-25       Impact factor: 4.733

7.  Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction.

Authors:  Qian Wang; Junfen Ma; Zhiyun Jiang; Fan Wu; Jiedan Ping; Liang Ming
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

8.  Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor.

Authors:  Peter Moritz Becher; Svenja Hinrichs; Nina Fluschnik; Jan K Hennigs; Karin Klingel; Stefan Blankenberg; Dirk Westermann; Diana Lindner
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

Review 9.  Post-infarct remodelling: contribution of wound healing and inflammation.

Authors:  Stefan Frantz; Johann Bauersachs; Georg Ertl
Journal:  Cardiovasc Res       Date:  2008-10-31       Impact factor: 10.787

10.  Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo.

Authors:  Haijie Yu; Liye Shi; Guoxian Qi; Shijie Zhao; Yuan Gao; Yuzhe Li
Journal:  Front Pharmacol       Date:  2016-06-01       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.